Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C
Alejandro Soza(National Institute of Diabetes and Digestive and Kidney Diseases), Jay H. Hoofnagle(National Institutes of Health), James E. Everhart(Memorial Health University Medical Center), Yoon Park(National Institute of Diabetes and Digestive and Kidney Diseases), Edward Doo(National Institutes of Health), Theo Heller(National Institutes of Health), Marc G. Ghany(National Institute of Diabetes and Digestive and Kidney Diseases), Kittichai Promrat(National Institute of Diabetes and Digestive and Kidney Diseases), Jake T. Liang(National Institutes of Health)
Cited by 216
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
|Hepatology|2008|3k
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k